Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > OX40 Ligand

OX40 Ligand

Brief Information

Name:Tumor necrosis factor ligand superfamily member 4
Target Synonym:CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Nec
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
OXL-H5243 Human Human OX40 Ligand / TNFSF4 Protein, His Tag, active trimer (MALS verified)
OXL-H5243-sds
OXL-H82F5 Human Biotinylated Human OX40 Ligand / TNFSF4 Protein, Fc,Avitag™, premium grade
OXL-H82F5-sds
OXL-C5243 Cynomolgus / Rhesus macaque Cynomolgus / Rhesus macaque OX40 Ligand Protein, His Tag, active trimer (MALS verified)
OXL-C5243-sds
CHEK-ATP054 Human HEK293/Human OX40 Ligand / TNFSF4 Stable Cell Line
OXL-R5248 Rat Rat OX40 Ligand / TNFSF4 Protein, His Tag (active trimer) (MALS verified)
OXL-R5248-sds
OXL-R5249 Rabbit Rabbit OX40 Ligand / TNFSF4 Protein, His Tag (active trimer) (MALS verified)
OXL-R5249-sds
OXL-H82Q5 Human Biotinylated Human OX40 Ligand / TNFSF4 Protein, His,Avitag™, active trimer (MALS verified)
OXL-H82Q5-sds
OXL-H5266 Human Human OX40 Ligand / TNFSF4 Protein, Fc Tag, premium grade
OXL-H5266-sds
OXL-H82F4 Human Biotinylated Human OX40 Ligand / TNFSF4 Protein, Avitag™,Fc Tag
OXL-H82F4-structure
OXL-H82F4-sds
OXL-H5250 Human Human OX40 Ligand / TNFSF4 Protein, Mouse IgG2a Fc Tag, low endotoxin
OXL-H5250-structure
OXL-H5250-sds
OXL-R5259 Cynomolgus / Rhesus macaque Cynomolgus / Rhesus macaque OX40 Ligand / TNFSF4 Protein, Mouse IgG2a Fc Tag
OXL-R5259-structure
OXL-R5259-sds
TN4-M5241 Mouse Mouse OX40 Ligand / TNFSF4 Protein, His Tag
TN4-M5241-structure
TN4-M5241-sds
OXL-M526x Mouse Mouse OX40 Ligand / TNFSF4 Protein, Fc Tag
OXL-M526x-structure
OXL-M526x-sds
OXL-H52Q8 Human Human OX40 Ligand / TNFSF4 Protein, His Tag, active trimer (MALS verified)
OXL-H52Q8-structure
OXL-H52Q8-sds
ACRO Quality

Part of Bioactivity data

CHEK-ATP054-Cell-based assay
OX40 Ligand FACS

FACS assay shows that Biotinylated Human OX40, Avitag,His Tag (TN4-H82E4) can bind to HEK293/Human OX40 Ligand / TNFSF4 Stable Cell Line (CHEK-ATP054). HEK293/Human OX40 Ligand / TNFSF4 Stable Cell Line was red line, Negative control HEK293 cells was grey line (QC tested).

Protocol
OXL-H5250-Cell-based assay
OX40 Ligand FACS

FACS assay shows that recombinant Human OX40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. OXL-H5250) can bind to 293T cell overexpressing human OX40. The concentration of OX40 Ligand is 0.003 μg/ml (Routinely tested).

Protocol
OXL-H5243-BLI
OX40 Ligand BLI

Loaded Biotinylated Human OX40, Avitag,His Tag (Cat. No. TN4-H82E4) on SA Biosensor, can bind Human OX40 Ligand Protein, His Tag (Cat. No. OXL-H5243) with an affinity constant of 91.3 pM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
OXL-H5250-BLI
OX40 Ligand BLI

Loaded Human OX40 Ligand Protein, Mouse IgG2a Fc Tag (Cat. No. OXL-H5250) on Protein A Biosensor, can bind Human OX40, His Tag (Cat. No. OX0-H5224) with an affinity constant of 2 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol

Synonym Name

OX40L,TNFSF4,CD252,Glycoprotein Gp34,TXGP1,CD134 ligand,CD134L

Background

Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on such cells as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. The interaction of TNFSF4-TNFSF4 is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. Furthermore, similar to other TNF superfamily members, membrane-bound OX40 Ligand (TNFSF4) exists as a homotrimer. Human TNFSF4 shares 46% amino acid sequence identity with its mouse counterpart.

Clinical and Translational Updates

Related Molecule

OX40

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Amlitelimab KY-1005; SAR-445229 Phase 3 Clinical Kymab Ltd, Sanofi Hidradenitis; Scleroderma, Systemic; Immune System Diseases; Lung Diseases, Interstitial; Asthma; Dermatitis, Atopic; Eczema Details
RP-3 RP-3 Phase 2 Clinical Replimune Inc Solid tumours; Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Carcinoma, Hepatocellular Details
HS-130 HS-130 Phase 1 Clinical Heat Biologics Solid tumours Details
anti-cancer mRNA therapeutics (Moderna Therapeutics) mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Melanoma Details
IMB-101 (IMBiologics) Phase 1 Clinical IMBiologics Corp Arthritis, Rheumatoid Details
IBI356 IBI356; IBI-356 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Autoimmune Diseases; Dermatitis, Atopic Details
SAR-443726 SAR-443726 Phase 1 Clinical Sanofi Dermatitis, Atopic Details
Amlitelimab KY-1005; SAR-445229 Phase 3 Clinical Kymab Ltd, Sanofi Hidradenitis; Scleroderma, Systemic; Immune System Diseases; Lung Diseases, Interstitial; Asthma; Dermatitis, Atopic; Eczema Details
RP-3 RP-3 Phase 2 Clinical Replimune Inc Solid tumours; Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Carcinoma, Hepatocellular Details
HS-130 HS-130 Phase 1 Clinical Heat Biologics Solid tumours Details
anti-cancer mRNA therapeutics (Moderna Therapeutics) mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Melanoma Details
IMB-101 (IMBiologics) Phase 1 Clinical IMBiologics Corp Arthritis, Rheumatoid Details
IBI356 IBI356; IBI-356 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Autoimmune Diseases; Dermatitis, Atopic Details
SAR-443726 SAR-443726 Phase 1 Clinical Sanofi Dermatitis, Atopic Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap